Target intelligence / Profile preview

Folliculin (FLCN)

Target
FLCN
Molecular classification
Tumor suppressor protein, GTPase activating protein (GAP), GEF (guanine nucleotide exchange factor) activity (for Rab35; limited evidence), DENN domain protein (structural similarity), Other (no strong homology to classical receptor, enzyme, transporter classes)
01

Overview

Folliculin is a highly conserved multifunctional protein with a key role in tumor suppression and homeostatic signaling, forming complexes with FNIP1 and FNIP2 and modulating AMPK and mTORC1 pathways. Loss-of-function mutations in FLCN cause autosomal dominant Birt-Hogg-Dubé syndrome, leading to renal neoplasia, skin papules (fibrofolliculomas), and pulmonary cysts. Structural studies show folliculin sharing features with DENN domain proteins, functioning as a GAP for Rag GTPases, thereby regulating lysosomal recruitment of mTORC1, autophagy, and transcription factors (TFEB/TFE3). Additional roles are described in cytoskeletal dynamics, cell adhesion, cell cycle control, and mitochondrial biogenesis. Interruption of folliculin activity drives cellular dysregulation and tumor predisposition, but no targeted therapies or direct inhibitors of FLCN are currently in clinical use.

Other names
Birt-Hogg-Dubé syndrome proteinBHD proteinDENND8BFLCLMGC17998MGC23445BHD skin lesion fibrofolliculoma proteinb/hd syndrome proteinfolliculin interacting protein partner
02

Mechanism of action

Drugs that modulate mTORC1 (e.g., mTOR inhibitors like rapamycin) may functionally intersect with FLCN downstream effects. No direct FLCN-targeting mechanisms currently established for approved therapies.

03

Biological functions

Regulation of mTORC1 pathway and cellular metabolismAMPK interaction and regulation of catabolic processesModulation of cell growth, division, and adhesionLysosomal biogenesis, autophagy, and transcriptional control through TFEB/TFE3Endocytosis, cytoskeletal organization, and membrane traffickingRegulation of mitochondrial biogenesis and oxidative metabolismRho A signaling and cell cycle regulation
04

Disease associations

Cancer (predisposition to renal cell carcinoma, fibrofolliculomas)Rare genetic syndrome (Birt-Hogg-Dubé syndrome)Lung disease (pulmonary cysts, spontaneous pneumothorax)
05

Safety considerations

No specific safety issues for FLCN inhibitors/modulators, as no therapies directly target FLCN yetTherapeutic targeting presents challenges due to its broad cellular roles and tumor suppressor natureLoss of folliculin contributes to tumorigenesis and multisystem disease; replacement or restoration (not inhibition) would theoretically be preferred
06

Interacting drugs

rapamycin (mTOR inhibitor, research/off-label context)

2 more in the full profile.

07

Biomarkers

FLCN mutation status (diagnostic and predictive for Birt-Hogg-Dubé syndrome, kidney cancer risk, skin/lung presentations)Loss of folliculin expression in tumor tissue (pathological biomarker)

Beyond the preview

Go deeper on Folliculin (FLCN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Folliculin (FLCN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call